IL1B and pemphigus foliaceus: The finding indicated that the MSC therapy group had a lower level of IL-1β compared to the control group (SMD = −3.24, 95%CI: −5.24, −1.24; p = 0.02; Table 3), which indicates that MSC treatment can down-regulate the level of IL-1β in PF animal models (Figure 4).